BB
TEVA icon

Busey Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Busey Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-325
Closed -$3K – 439
2019
Q4 		$3K Buy
+325
New +$2.9K ﹤0.01% 451
2015
Q2 		– Sell
-3,233
Closed -$202K – 211
2015
Q1 		$202K Buy
+3,233
New +$188K 0.03% 200
2014
Q4 		– Sell
-3,764
Closed -$202K – 213
2014
Q3 		$202K Buy
+3,764
New +$199K 0.03% 195
2013
Q4 		– Sell
-152,226
Closed -$5.75M – 185
2013
Q3 		$5.75M Buy
152,226
+16,952
+13% +$661K 0.95% 50
2013
Q2 		$5.3M Buy
+135,274
New +$5.27M 0.89% 49

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Busey Bank's TEVA Position: Q1 2020 in Review

Busey Bank sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 325 shares — an estimated $3K sold.

Busey Bank first reported a position in TEVA in Q2 2013 and held it in 5 quarters. The position peaked at $5.75M in Q3 2013. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

  • Busey Bank reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Busey Bank sold 325 Teva Pharmaceuticals shares in Q1 2020, an estimated $3K.
  • Busey Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 5 quarters.
  • Busey Bank's Teva Pharmaceuticals position peaked at $5.75M in Q3 2013.
  • 459 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on Busey Bank's 13F filing for Q1 2020, filed 17 Apr 2020.